Literature DB >> 20013278

Use of intrathecal urokinase in repeated shunt and external ventricular drain blockage from high CSF protein due to an optic pathway glioma.

David Shooman1, Girish V Vajramani, Jennifer Davidson, Owen C Sparrow.   

Abstract

INTRODUCTION: High cerebrospinal fluid (CSF) protein is a recognised association of optic pathway gliomas. This can occlude ventriculoperitoneal (VP) shunt catheters or external ventricular drains (EVD). CASE REPORT: We describe an 8-year-old boy with an optic pathway glioma, who had frequent episodes of a blocked VP shunt and EVD due to high CSF protein level. This responded favourably to repeated urokinase instillation into the catheter lumen. We present the course of treatment and the method of administration and review the literature behind thrombolytic therapy for occluded catheter devices.
CONCLUSION: Intrathecal urokinase was effective in unblocking the EVD and lysing the protein clots within the ventricle. We found no previously published cases of intrathecal urokinase for this problem. This novel intervention seemed promising as a safe and effective means of maintaining EVD patency in cases complicated by excessive protein loads in CSF and hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013278     DOI: 10.1007/s00381-009-1064-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  14 in total

1.  Treatment of hydrocephalus: an historical and critical review of methods and results.

Authors:  J E SCARFF
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-02       Impact factor: 10.154

2.  Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption.

Authors:  H L Brydon; G Keir; E J Thompson; R Bayston; R Hayward; W Harkness
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  A ventriculo-peritoneal shunt for hemorrhagic or high protein fluid.

Authors:  J H Salmon
Journal:  Surg Neurol       Date:  1977-07

4.  Optic chiasm glioma, electrolyte abnormalities, nonobstructive hydrocephalus and ascites.

Authors:  A Shuper; G Horev; S Michovitz; L Korenreich; R Zaizov; I J Cohen
Journal:  Med Pediatr Oncol       Date:  1997-07

5.  Coagulation and fibrinolytic activity of cerebrospinal fluid.

Authors:  M Anderson; K B Matthews; J Stuart
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

6.  Treatment of intraventricular hemorrhage using urokinase.

Authors:  P H Shen; Y Matsuoka; K Kawajiri; M Kanai; K Hoda; S Yamamoto; S Nishimura
Journal:  Neurol Med Chir (Tokyo)       Date:  1990-05       Impact factor: 1.742

Review 7.  The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.

Authors:  John F Deeken; Wolfgang Löscher
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

8.  Does the cerebrospinal fluid protein concentration increase the risk of shunt complications?

Authors:  H L Brydon; R Hayward; W Harkness; R Bayston
Journal:  Br J Neurosurg       Date:  1996-06       Impact factor: 1.596

9.  Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial.

Authors:  Neal J Naff; Daniel F Hanley; Penelope M Keyl; Stanley Tuhrim; Michael Kraut; Joshua Bederson; Ross Bullock; Stephan A Mayer; Eric Schmutzhard
Journal:  Neurosurgery       Date:  2004-03       Impact factor: 4.654

10.  Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement.

Authors:  G A West; M S Berger; J R Geyer
Journal:  Pediatr Neurosurg       Date:  1994       Impact factor: 1.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.